Max Healthcare Institute Limited (MAXHEALTH.NS) Seasonal returns chart
NiveshIQ
Aster DM Healthcare Ltd.
NiveshIQ has detected 5 active signals on ASTERDM. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Aster DM Healthcare Ltd.
Aster DM Quality Care Limited (ASTERDM) operates as an integrated healthcare provider in India, delivering services across hospitals & clinics, diagnostic labs, wholesale pharmacies, optical outlets, and digital health platforms under brands such as Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH. The company’s revenue mix is driven by its multi‑specialty hospitals (cardiac sciences, oncology, gastroenterology, orthopaedics, women’s and child health), diagnostic labs (notably Lal PathLabs with an EBITDA margin of 31%), and wholesale pharmacy operations. In FY26, combined revenue reached ₹9,273 crore, with a net income of ₹319 crore, reflecting a 35.3% revenue growth in the KIMS segment and strong performance in diagnostics. Aster DM’s competitive position is reinforced by its diversifie
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,699 Cr -69.00% | ₹4,138 Cr +11.88% | ₹4,643 Cr +12.20% |
| EBITDA Margin | 15.62% | 18.47% | 19.41% |
| Net Profit | ₹129.28 Cr -69.57% | ₹5,378 Cr +4059.83% | ₹388.14 Cr -92.78% |
| EPS | ₹2.60 | ₹107.98 | ₹7.53 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Max Healthcare Institute Limited (MAXHEALTH.NS) Seasonal returns chart
Max Healthcare Institute Limited (MAXHEALTH.NS) Seasonal returns chart
Strategic Outlook
- Q1FY27 results: revenue ₹1, 311 Cr, PAT ₹16 Cr, EPS ₹0.31, EBITDA margin 20.2%. Growth context: revenue YoY +21.6%, PAT YoY -81.2%, revenue QoQ +10.9%, PAT QoQ -88.5%. Street verdict: miss, revenue surprise +4.9%, PAT surprise -85.4%.
Test volumes, test mix, B2B/reference-lab traction, pricing discipline, and operating leverage remain the key forward dr...
FY26 (last completed FY): revenue ₹4, 643 Cr, PAT ₹388 Cr, EBITDA margin 19.4%, EPS ₹7.53. Year-on-year: revenue YoY +12...
More Healthcare stocks
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Aster DM Healthcare Ltd.?
NiveshIQ detects active intelligence signals for Aster DM Healthcare Ltd. (ASTERDM) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Aster DM Healthcare Ltd.?
Aster DM Healthcare Ltd. operates in the Healthcare sector with a market capitalisation of ₹6,845,679.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.